Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 01.06.2026 1 ACS Nano 1 Adv Healthc Mater 1 Am J Vet Res 1 Ann Am Thorac Soc 1 Arterioscler Thromb Vasc Biol 1 Biomed Pharmacother 1 Br J Pharmacol 1 Case Rep Pediatr 1 Cell Signal 1 Chest 2 Children (Basel) 1 Circ J 2 Circulation 1 Compr Physiol 2 Curr Opin Pulm Med 1 Eur Heart J Imaging Methods Pract 1 Eur J Gastroenterol Hepatol 5 Front Cardiovasc Med 1 Front Med (Lausanne) 1 Future Cardiol 1 Int J Cardiol Congenit Heart Dis 1 Int J Gen Med 1 Int J Mol Sci 1 J Basic Clin Physiol Pharmacol 2 J Cardiovasc Dev Dis 1 J Med Chem 1 J Patient Saf 2 J Pediatr 1 J Thorac Cardiovasc Surg 1 J Thromb Thrombolysis 1 J Transl Med 2 J Vis Exp 1 JACC Adv 1 Life Sci 1 Med Sci (Basel) 1 Medicina (Kaunas) 1 Nat Commun 1 Neuropeptides 1 Orv Hetil 1 Pediatr Cardiol 1 Pediatr Neonatol 3 Physiol Res 3 PLoS One 1 Pulmonology 1 Respir Investig 1 Respir Med 1 Rev Esp Cardiol (Engl Ed) 1 Shock

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

ACS Nano

1. ZHAO J, Shi G, Han H, Zeng M, et al
   Dual-Scale Liposomal Assembly Enables Alveolar Macrophage-Targeted Gene Delivery in High-Altitude Pulmonary Edema and Acute Lung Injury.
   ACS Nano. 2026;20:14458-14478.
   PubMed         Abstract available
   
   

   
   Adv Healthc Mater

2. SI S, Wang H, Xu Y, Wang J, et al
   Scalable Production of Multi-Source Hybrid Biomimetic Exosomes Co-Loaded with Therapeutic Plasmids for Treatment of High-Altitude Pulmonary Edema.
   Adv Healthc Mater. 2026;15:e04014.
   PubMed         Abstract available
   
   

   
   Am J Vet Res

3. SILVA VBC, Lucina SB, Wolf M, Sarraff AP, et al
   Right ventricular systolic function in dogs with pulmonary hypertension can be assessed using tissue motion annular displacement.
   Am J Vet Res. 2026 May 26:1-8. doi: 10.2460/ajvr.26.03.0107.
   PubMed         Abstract available
   
   

   
   Ann Am Thorac Soc

4. MCCARTHY BE, Feng R, Bernardo R, Shlobin OA, et al
   Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
   Ann Am Thorac Soc. 2026 May 29:aaoag141. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Arterioscler Thromb Vasc Biol

5. YUAN H, Chen B, Gao D, Zhang L, et al
   I-tRF-Asp Promotes Vascular Remodeling in Hypoxic Pulmonary Hypertension Via hnRNPU Phase Separation, Which Affects TCF7L2 Alternative Splicing.
   Arterioscler Thromb Vasc Biol. 2026 May 28. doi: 10.1161/ATVBAHA.126.324681.
   PubMed         Abstract available
   
   

   
   Biomed Pharmacother

6. LI X, Li H, Feng B, Chen X, et al
   Expression of concern to "Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition" [Biomed. Pharmacother. 177 (2024) 117023].
   Biomed Pharmacother. 2026;199:119313.
   PubMed        
   
   

   
   Br J Pharmacol

7. DIENER J, Soni H, Booe J, Darce J, et al
   Development of a long-acting relaxin for the treatment of pulmonary hypertension.
   Br J Pharmacol. 2026 May 22. doi: 10.1111/bph.70498.
   PubMed         Abstract available
   
   

   
   Case Rep Pediatr

8. VANDERWILDE AJ, Miles KG, Becker KC, Critser PJ, et al
   Oxygen Consumption and Oxygen Pulse Patterns in Two Pediatric Patients With Pulmonary Hypertension and Different Clinical Responses: A Case Report.
   Case Rep Pediatr. 2026;2026:6697634.
   PubMed         Abstract available
   
   

   
   Cell Signal

9. LU H, Zhang M, Gong S, Liang N, et al
   The CCL2 network in pulmonary hypertension: Potential therapeutic targets.
   Cell Signal. 2026;145:112606.
   PubMed         Abstract available
   
   

   
   Chest

10. GARCIA AR, Vollmer I, Blanco I, San Jose Estepar R, et al
    Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease.
    Chest. 2026 May 27:S0012-3692(26)00704-X. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    

    
    Children (Basel)

11. VYAS-READ S, Bhombal S, Siddaiah R, Cua CL, et al
    Echocardiographic Detection of Pulmonary Hypertension and Right Ventricular Failure in Infants with Bronchopulmonary Dysplasia: A Survey of the BPD Collaborative.
    Children (Basel). 2026;13:646.
    PubMed         Abstract available
    
    
12. SUN Y, Zhang Q, Huang Y, Liu X, et al
    A Rare Case of Multi-System Involvement and Hereditary Pulmonary Hypertension Caused by De Novo Heterozygous CAV1 Mutation in a Pediatric Patient.
    Children (Basel). 2026;13:694.
    PubMed         Abstract available
    
    

    
    Circ J

13. IWAHORI T, Hayashi Y, Tsuchiya H, Hirata T, et al
    Regional Disparities in Access to Specialized Facilities and Prescription Preference for Initial Pulmonary Arterial Hypertension Treatment?- A Nationwide Study Using the National Database of Health Insurance Claims.
    Circ J. 2026;90:736-738.
    PubMed         Abstract available
    
    

    
    Circulation

14. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
    Correction to: Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
    Circulation. 2026;153:e1362.
    PubMed        
    
    
15. HOU Y, Li Q, Wei TW, Lin X, et al
    Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways.
    Circulation. 2026 May 26. doi: 10.1161/CIRCULATIONAHA.124.073606.
    PubMed         Abstract available
    
    

    
    Compr Physiol

16. TARRAS ES, Arun AS, Joseph P, Heerdt PM, et al
    Right Ventricular End-Ejection Pressure Predicts Mortality in Patients With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
    Compr Physiol. 2026;16:e70187.
    PubMed         Abstract available
    
    

    
    Curr Opin Pulm Med

17. GUY K, Isaiah A
    Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome.
    Curr Opin Pulm Med. 2026 May 26. doi: 10.1097/MCP.0000000000001287.
    PubMed         Abstract available
    
    
18. LEUZZI FR, Clausen ES, Dilling DF
    The changing face of lung transplant candidates.
    Curr Opin Pulm Med. 2026;32:335-340.
    PubMed         Abstract available
    
    

    
    Eur Heart J Imaging Methods Pract

19. AMIRI U, Keceli E, Andersen MO, Mojaddedi S, et al
    Advanced right ventricular evaluation in pulmonary hypertension: the role of 3D echocardiography and strain analysis.
    Eur Heart J Imaging Methods Pract. 2026;4:qyag067.
    PubMed         Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

20. TAZIBT D, Vacelet V, Vendeville S, Seronde MF, et al
    Coexistence of hepatopulmonary syndrome and portopulmonary hypertension before a liver transplantation: a case report and review of the literature.
    Eur J Gastroenterol Hepatol. 2026;38:874-878.
    PubMed         Abstract available
    
    

    
    Front Cardiovasc Med

21. SCABELLO RT, de Carvalho-Pinto RM, de Parodi LN, de Almeida G, et al
    Prevalence, pathogenesis, and clinical impact of pulmonary hypertension associated with chronic obstructive pulmonary disease.
    Front Cardiovasc Med. 2026;13:1700063.
    PubMed         Abstract available
    
    
22. GHANI H, Thillai M, Walsh S, Bussell E, et al
    Anthropometry, sex, and age at diagnosis affect pulmonary blood volume quantification from computed tomography pulmonary angiography in pulmonary hypertension assessment.
    Front Cardiovasc Med. 2026;13:1815977.
    PubMed         Abstract available
    
    
23. ANDROSHCHUK V, Long E, Sillett C, Chehab O, et al
    Multi-chamber three-dimensional myocardial strain assessment by computed tomography: a comparison with speckle tracking echocardiography and association with pulmonary hypertension in severe aortic stenosis.
    Front Cardiovasc Med. 2026;13:1774091.
    PubMed         Abstract available
    
    
24. KRASIC S, Hermuzi A, Dizdarevic I, Topic V, et al
    Case Report: Post-Total anomalous pulmonary venous connection pulmonary hypertension - novel treatment using sirolimus and atrial flow regulator implantation.
    Front Cardiovasc Med. 2026;13:1783773.
    PubMed         Abstract available
    
    
25. YOO HHB, Rroku A, Thevathasan T
    Editorial: Pulmonary embolism and pulmonary hypertension: from acute management to long-term phenotyping.
    Front Cardiovasc Med. 2026;13:1851852.
    PubMed        
    
    

    
    Front Med (Lausanne)

26. GILBOA-SAGY H, Romem A, Guber E, Epstein Shochet G, et al
    Transbronchial cryobiopsy is safe for patients with echocardiographic evidence of pulmonary hypertension: a blinded prospective cohort study.
    Front Med (Lausanne). 2026;13:1842852.
    PubMed         Abstract available
    
    

    
    Future Cardiol

27. SALIBE-FILHO W, Zorze Rossetto N, Tatagiba LS, de Deus MontAlverne Parente Y, et al
    Evaluating sotatercept in the treatment of pulmonary arterial hypertension.
    Future Cardiol. 2026;22:463-472.
    PubMed         Abstract available
    
    

    
    Int J Cardiol Congenit Heart Dis

28. ISHII T, Anzai T, Uchida K, Hosokawa S, et al
    Registry-based estimation of cardiac event-free survival in congenital heart disease complicated by pulmonary hypertension: A nationwide registry study from Japan.
    Int J Cardiol Congenit Heart Dis. 2026;25:100679.
    PubMed         Abstract available
    
    

    
    Int J Gen Med

29. ZHOU Q, Zhu G, Zhang P, Qi B, et al
    Construction and Validation of a Predictive Model for Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension Based on Lasso Regression.
    Int J Gen Med. 2026;19:599529.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

30. CHADDA KR, Sathivelu S, Armstrong SK, Edling C, et al
    Rare Models: Use of a Novel Translational Model for Diffuse Alveolar Haemorrhage.
    Int J Mol Sci. 2026;27:4157.
    PubMed         Abstract available
    
    

    
    J Basic Clin Physiol Pharmacol

31. HE P, Tan W, Zhu Y, Fan J, et al
    Ginsenoside Rg1 attenuates right ventricular remodeling in hypoxic pulmonary hypertension and is associated with suppression of HIF-1alpha-related glycolytic signaling.
    J Basic Clin Physiol Pharmacol. 2026 May 28. doi: 10.1515/jbcpp-2026-0090.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Dev Dis

32. RAMAZANI N, Barnes L, Wong A, Sharma D, et al
    The New Era of Pulmonary Hypertension: The Dawn of Disease Modification & Therapeutic Modalities.
    J Cardiovasc Dev Dis. 2026;13:174.
    PubMed         Abstract available
    
    
33. CHEN Z, Pang L, Zheng Y, Xu L, et al
    Multi-Omics Identification of Biomarkers for High-Altitude Pulmonary Hypertension.
    J Cardiovasc Dev Dis. 2026;13:195.
    PubMed         Abstract available
    
    

    
    J Med Chem

34. LI M, Wang Y, Liang X, Zhao C, et al
    Identification of an Hsp110/HDAC6 Dual-Target Inhibitor for the Effective Treatment of Pulmonary Arterial Hypertension via Synergistic Blockade of Vascular Remodeling.
    J Med Chem. 2026;69:12205-12222.
    PubMed         Abstract available
    
    

    
    J Patient Saf

35. PAVULURI SK, Zahn E, Sather J, Finocchio T, et al
    Eliminating a Latent Safety Threat in Emergency Care: A High-Reliability, Automated Strategy for Prostacyclin Continuity in Pulmonary Hypertension Patients.
    J Patient Saf. 2026 May 22. doi: 10.1097/PTS.0000000000001499.
    PubMed        
    
    

    
    J Pediatr

36. BERGER RMF, Dunbar Ivy D, Borissoff JI, Cerovic S, et al
    Macitentan in Pediatric Pulmonary Arterial Hypertension (TOMORROW): A Randomized Clinical Trial.
    J Pediatr. 2026;293:115057.
    PubMed         Abstract available
    
    
37. WREN JT JR, Hyland RM, McNamara PJ
    Initial Hemodynamic Phenotypes and Clinical Trajectory in Congenital Diaphragmatic Hernia: A Pilot Study.
    J Pediatr. 2026 Feb 19:115044. doi: 10.1016/j.jpeds.2026.115044.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

38. GEUBE M, Abraham A, Kelava M, Bustamante SE, et al
    Cardiopulmonary Effects of Vasopressin Versus Norepinephrine in Cardiac Surgery Patients: a Single Cluster-Randomized Cross-over Trial.
    J Thorac Cardiovasc Surg. 2025 Nov 19:S0022-5223(25)00978.
    PubMed         Abstract available
    
    

    
    J Thromb Thrombolysis

39. ZHENG K, Zheng X, Li J, Xu M, et al
    Single-cell transcriptomics reveals NDRG1/TGF?beta1 associated vascular smooth muscle cell phenotypic switching in chronic thromboembolic pulmonary hypertension.
    J Thromb Thrombolysis. 2026 May 29. doi: 10.1007/s11239-026-03288.
    PubMed         Abstract available
    
    

    
    J Transl Med

40. CHEN M, Liao X, Li F, Liu J, et al
    The MCP-1/CCR2-CD16(+) monocyte axis drives thrombus fibrosis in Chronic Thromboembolic Pulmonary Hypertension.
    J Transl Med. 2026 May 28. doi: 10.1186/s12967-026-08283.
    PubMed         Abstract available
    
    

    
    J Vis Exp

41. WHITE YN, Douglass M, Van Boerum J, Rebentisch A, et al
    Cardiac Catheterization for Assessment of Pulmonary Hypertension in Preterm Lambs.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    
42. BULARD BA, Kumpfbeck AR, Woo Y, Simonds E, et al
    Structured Exercise Regimen in Pulmonary Hypertension-Right Ventricular Failure in an Ovine Model.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    

    
    JACC Adv

43. KHURANA JK, Lipsitz S, Geisser DL, Moynihan KM, et al
    Child Opportunity Index Influences Pediatric Pulmonary Hypertension Outcomes: Analyses From the Pediatric Health Information System.
    JACC Adv. 2026;5:102773.
    PubMed         Abstract available
    
    

    
    Life Sci

44. ZHOU WY, Wu XL, Wang SY, Zhang XY, et al
    TBX5-GATA4 interaction aggravates pulmonary artery smooth muscle proliferation and pathogenesis of pulmonary arterial hypertension through transcriptional co-activating CDK18.
    Life Sci. 2026;398:124453.
    PubMed         Abstract available
    
    

    
    Med Sci (Basel)

45. ERAKY AM, Mokhtar Y, Grabau G, Khan A, et al
    Calcium Channel Blockers in Critical Care Medicine: Current Clinical Applications and Future Investigational Perspectives.
    Med Sci (Basel). 2026;14:213.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

46. CONDE-CAMACHO R, Tuta-Quintero E, Mora-Barrero A, Bastidas-Goyes A, et al
    Hemodynamic and Thrombotic Vulnerability in Pulmonary Arterial Hypertension at High Altitude: Multivariable Predictors of Mortality.
    Medicina (Kaunas). 2026;62:996.
    PubMed         Abstract available
    
    

    
    Nat Commun

47. QIU L, Lu T, Zhang J, Liu M, et al
    Targeting REV-ERBalpha/BNIP3 axis attenuates pulmonary arterial hypertension by repressing mitophagy in mice.
    Nat Commun. 2026;17:4793.
    PubMed         Abstract available
    
    

    
    Neuropeptides

48. HUANG S, Chen Z, Gong W, Song Y, et al
    Kisspeptin-10 attenuates pulmonary arterial hypertension via restoration of mitochondrial function in pulmonary artery smooth muscle cells.
    Neuropeptides. 2026;117:102611.
    PubMed         Abstract available
    
    

    
    Orv Hetil

49. LANTOS L, Somogyvari Z, Szell A, Belteki G, et al
    [Use of inhaled nitric oxide during neonatal transport - a review of seven years of experience].
    Orv Hetil. 2026;167:824-832.
    PubMed         Abstract available
    
    

    
    Pediatr Cardiol

50. CUSTODIO JM, Rodgers N, Aggarwal V
    Digital Subtraction Pulmonary Angiography: A Useful Tool to Evaluate Pediatric Pulmonary Hypertension.
    Pediatr Cardiol. 2026 May 25. doi: 10.1007/s00246-026-04311.
    PubMed         Abstract available
    
    

    
    Pediatr Neonatol

51. LIU HY, Cheng MC, Chien SJ, Lin YJ, et al
    The impact and outcome of the presence of ductus arteriosus in neonatal peripheral extracorporeal membrane oxygenation.
    Pediatr Neonatol. 2026;67:288-292.
    PubMed         Abstract available
    
    

    
    Physiol Res

52. LIU Z, Liu X, Mprah R, Sun H, et al
    Sodium Selenite Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension by Upregulating GPX3 and Ameliorating Vascular Remodeling.
    Physiol Res. 2026;75:325-335.
    PubMed         Abstract available
    
    
53. WANG D, Li Y, Wang H, Zhang J, et al
    Shortened Pulmonary Pulse Wave Transit Time in High-Altitude Residents Without Pulmonary Hypertension: An Doppler Echocardiography Study.
    Physiol Res. 2026;75:315-323.
    PubMed         Abstract available
    
    
54. WANG D, Fang Y, Wu X, Zhang J, et al
    Increased Right Ventricular Cardiac Output to Left Ventricular Cardiac Output Ratio in High-Altitude Residents Without Pulmonary Hypertension: An Echocardiography Study.
    Physiol Res. 2026;75:257-264.
    PubMed         Abstract available
    
    

    
    PLoS One

55. YUAN Z, Chen J, Chen D, Xu G, et al
    Correction: Megakaryocytic Leukemia 1 (MKL1) Regulates Hypoxia Induced Pulmonary Hypertension in Rats.
    PLoS One. 2026;21:e0350157.
    PubMed         Abstract available
    
    
56. YANG X, Zhou B, Yang Y, Dong Y, et al
    Integrative transcriptomic analysis identifies immune-associated candidate genes and altered immune cell infiltration in pulmonary arterial hypertension.
    PLoS One. 2026;21:e0350015.
    PubMed         Abstract available
    
    
57. PAN Q, Chen H, Pan H, Hu Z, et al
    Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database.
    PLoS One. 2026;21:e0346792.
    PubMed         Abstract available
    
    

    
    Pulmonology

58. TRINDADE P, Dias A, Santos FP, Froes F, et al
    Management of acute respiratory failure in pulmonary hypertension in the ICU: Ten years of experience.
    Pulmonology. 2026;32:2679340.
    PubMed        
    
    

    
    Respir Investig

59. TERAMACHI R, Fukihara J, Ichihara S, Kataoka K, et al
    Early risk response to vasodilators and outcomes in interstitial lung disease associated pulmonary hypertension.
    Respir Investig. 2026;64:101453.
    PubMed         Abstract available
    
    

    
    Respir Med

60. LUO Q, Li S, Huang Z, Ran Y, et al
    Prognostic value of TAPSE/sPAP in pulmonary arterial hypertension: a systematic review and meta-analysis.
    Respir Med. 2026;258:108861.
    PubMed         Abstract available
    
    

    
    Rev Esp Cardiol (Engl Ed)

61. LUNA-LOPEZ R, Garcia-Alvarez A
    Growing with the patient: toward a lifespan risk score for pediatric pulmonary hypertension.
    Rev Esp Cardiol (Engl Ed). 2026 May 27:S1885-5857(26)00107.
    PubMed        
    
    

    
    Shock

62. HUANG W, Wang X, Wu W, Wang Y, et al
    SMAD7 Downregulation Promotes Ferroptosis in Pulmonary Arterial Hypertension Via the TGF-beta1-SMAD2/3 Pathway.
    Shock. 2026;65:1021-1036.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum